Interestingly, in silico screening predicts that embelin inhibits the X-linked inhibitor of apoptosis protein (XIAP), which is over-expressed in a variety of cancers, especially drug-resistant ones (Nikolovska-Coleska et al., 2004; Hussain et al., 2017). This evidence concerns the gene XIAP and cancer.